Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: COMPASS Pathways plc

Market Cap 1.7B 1.5B 1.38B 1.29B 2.42B 161B 2.46B 16.57B 6.41B 79.22B 6.4B 6.26B 275B P/E 2026 *
-12.3x
P/E 2027 * -8.86x
Enterprise Value 1.28B 1.12B 1.04B 970M 1.82B 121B 1.85B 12.44B 4.82B 59.51B 4.81B 4.7B 207B EV / Sales 2026 *
-
EV / Sales 2027 * 20.1x
Free-Float
25.07%
Yield 2026 *
-
Yield 2027 * -
1 day+0.16%
1 week+10.10%
Current month-3.14%
1 month+3.48%
3 months+136.89%
6 months+83.60%
Current year+83.33%
1 week 11.51
Extreme 11.5105
13.15
1 month 10.72
Extreme 10.724
14.76
Current year 4.88
Extreme 4.88
14.76
1 year 2.35
Extreme 2.35
14.76
3 years 2.25
Extreme 2.25
14.76
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Chairman 74 29/03/2024
Director/Board Member 69 01/04/2020
Director/Board Member 66 01/03/2021
Date Insider Type Main position Quantity % Market Cap.
05-27Free

Director

21,110 0.0220%
05-27Free

Director

21,110 0.0220%
05-27Free

Chairman

30,158 0.0314%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+10.10%+438.30%+60.94% 1.7B
+2.96%+4.08%-8.03%-2.24% 43.24B
+2.23%+8.26%+323.35%+564.22% 35.25B
+1.59%+4.63%+7.23%+54.02% 30.22B
+2.07%-4.40%+10.38%-19.99% 28.01B
-4.75%-8.29%+3.90%+13.88% 24.08B
+4.64%+3.20% - - 14.16B
+3.91%+2.57%+53.41%+111.95% 13.01B
+2.77%+2.93%+9.65%+11.90% 12.7B
+0.13%+3.97%+101.73%+91.70% 12.54B
Average +1.54%+0.01%+104.43%+98.49% 21.49B
Weighted average by Cap. +1.57%-0.66%+72.20%+119.86%

Financials

2026 *2027 *
Net sales - 60.17M 52.86M 48.71M 45.6M 85.43M 5.7B 86.87M 585M 226M 2.8B 226M 221M 9.72B
Net income -100M -88.14M -81.22M -76.03M -142M -9.5B -145M -975M -378M -4.66B -377M -369M -16.21B -198M -174M -161M -150M -282M -18.78B -286M -1.93B -746M -9.22B -744M -728M -32.03B
Net Debt -424M -373M -343M -321M -602M -40.18B -612M -4.12B -1.6B -19.71B -1.59B -1.56B -68.51B -493M -433M -399M -374M -700M -46.71B -712M -4.79B -1.86B -22.92B -1.85B -1.81B -79.66B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
24/06/26 $12.65 +0.16% 2,349,106
22/06/26 $12.63 +0.80% 3,294,361
18/06/26 $12.53 +4.94% 3,625,329
17/06/26 $11.94 +3.92% 2,079,337
16/06/26 $11.49 -2.54% 2,055,662
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
12.63USD
Average target price
22.20USD
Spread / Average Target
+75.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!